Prevest Denpro Ltd Falls to 52-Week Low Amidst Continued Downtrend

2 hours ago
share
Share Via
Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has touched a new 52-week low of Rs.365.6 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.
Prevest Denpro Ltd Falls to 52-Week Low Amidst Continued Downtrend

Stock Price Movement and Market Context

On 20 Mar 2026, Prevest Denpro Ltd’s share price declined by 2.79% intraday, reaching Rs.365.6, the lowest level in the past year. This drop comes after two consecutive days of losses, during which the stock has fallen by 6.51%. The day’s performance also saw the stock underperform its Healthcare Services sector by 1.49%. Notably, the share price is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish technical setup.

In contrast, the broader market has shown resilience. The Sensex opened 352.14 points higher and climbed further by 455.29 points to close at 75,014.67, a gain of 1.09%. Despite this, the Sensex remains 4.79% above its own 52-week low of 71,425.01 and is trading below its 50-day moving average, with the 50 DMA itself below the 200 DMA, indicating some underlying market caution. Mega-cap stocks have been the primary drivers of the Sensex’s gains, while smaller stocks like Prevest Denpro have lagged behind.

Financial Performance and Valuation Metrics

Prevest Denpro’s one-year stock performance has been disappointing, with a decline of 16.12%, significantly underperforming the Sensex’s modest fall of 1.81% over the same period. The stock’s 52-week high was Rs.622.05, highlighting the extent of the recent correction.

From a fundamental perspective, the company’s operating profit has grown at a compounded annual rate of 12.49% over the last five years, which is considered modest within the sector. The half-yearly return on capital employed (ROCE) stands at 22.79%, the lowest recorded in recent periods, while the debtors turnover ratio is also at a low of 6.53 times, indicating slower collection cycles.

Despite these challenges, Prevest Denpro maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure. However, the return on equity (ROE) is 17%, which, combined with a price-to-book value of 3.9, suggests the stock is trading at a relatively expensive valuation compared to its historical averages and peers.

Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!

  • - Latest weekly selection
  • - Target price delivered
  • - Large Cap special pick

See This Week's Special Pick →

Comparative Performance and Market Positioning

Over the past year, while Prevest Denpro’s profits have increased by 17%, the stock’s price-to-earnings growth (PEG) ratio stands at 1.4, indicating that the market has not fully rewarded this earnings growth. The stock has also underperformed the BSE500 index over the last three years, one year, and three months, reflecting below-par performance both in the long and near term.

Prevest Denpro’s Mojo Score is 31.0, with a Mojo Grade of Sell, downgraded from Hold on 6 Nov 2025. This downgrade reflects the company’s subdued growth prospects and valuation concerns. The stock’s micro-cap market capitalisation further adds to its risk profile, as liquidity and volatility tend to be higher in this segment.

Technical Indicators and Market Sentiment

Technical analysis reveals a predominantly bearish outlook. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly charts. Bollinger Bands also signal bearish momentum across these timeframes. The daily moving averages confirm this downtrend, while the Know Sure Thing (KST) indicator shows mild bullishness weekly but mild bearishness monthly. Dow Theory assessments align with a mildly bearish stance on both weekly and monthly scales. The Relative Strength Index (RSI) does not currently signal any strong momentum, remaining neutral.

These technical signals, combined with the stock’s price trading below all major moving averages, suggest that the current market sentiment towards Prevest Denpro remains cautious.

Why settle for Prevest Denpro Ltd? SwitchER evaluates this Healthcare Services micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Shareholding and Capital Structure

The majority ownership of Prevest Denpro Ltd rests with its promoters, who maintain significant control over the company’s strategic direction. The company’s low debt levels, with an average debt-to-equity ratio of zero, indicate a conservative approach to leverage, which may provide some stability amid market fluctuations.

However, the combination of a micro-cap status, subdued growth rates, and valuation concerns has contributed to the stock’s recent decline and its fall to the 52-week low.

Summary of Key Metrics

To summarise, Prevest Denpro Ltd’s current share price of Rs.365.6 represents a 52-week low, reflecting a 16.12% decline over the past year. The stock’s valuation metrics, including a price-to-book value of 3.9 and a PEG ratio of 1.4, suggest that the market is cautious despite profit growth of 17%. Technical indicators predominantly signal bearish momentum, and the stock trades below all major moving averages. The company’s financial ratios, such as ROCE at 22.79% and debtors turnover at 6.53 times, are at their lowest recent levels, further underscoring the challenges faced.

While the broader market and mega-cap stocks have shown strength, Prevest Denpro’s micro-cap status and sector-specific factors have contributed to its underperformance. The downgrade to a Sell grade by MarketsMOJO on 6 Nov 2025 reflects these ongoing concerns.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Prevest Denpro Ltd Stock Falls to 52-Week Low of Rs.393
Mar 19 2026 10:04 AM IST
share
Share Via
Prevest Denpro Ltd Stock Falls to 52-Week Low of Rs.393
Mar 19 2026 10:04 AM IST
share
Share Via
Prevest Denpro Ltd is Rated Sell
Mar 10 2026 10:10 AM IST
share
Share Via
Prevest Denpro Ltd is Rated Sell
Feb 26 2026 10:10 AM IST
share
Share Via